The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety from the phase 1/2 MonumenTAL-1 study of talquetamab, a GPRC5D×CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma: Analyses at an extended median follow-up.
 
Leo Rasche
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Johnson & Johnson; Pfizer; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; GlaxoSmithKline; Johnson & Johnson; Pfizer; Pfizer; Sanofi
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - BeiGene
 
Carolina Schinke
Honoraria - Janssen; Pfizer
Consulting or Advisory Role - Janssen; Pfizer
 
Cyrille Touzeau
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Takeda
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen; Pfizer; Sanofi
 
Monique Minnema
Consulting or Advisory Role - Janssen-Cilag; Pfizer
Speakers' Bureau - Janssen-Cilag; Siemens
Research Funding - BeiGene
Travel, Accommodations, Expenses - BeiGene; Janssen-Cilag
 
Niels van de Donk
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bayer (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Janssen (Inst); MERCK (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Cellectis (Inst); Janssen (Inst); Novartis (Inst)
 
Paula Rodríguez-Otero
Honoraria - Abbvie; Celgene; GlaxoSmithKline; H3 Biomedicine; Janssen; Pfizer; Regeneron; Roche/Genentech; Sanofi
Consulting or Advisory Role - Abbvie; BMS; GlaxoSmithKline; Janssen; Pfizer; Roche; Sanofi
Speakers' Bureau - BMS; GlaxoSmithKline; Janssen; Sanofi
Travel, Accommodations, Expenses - Pfizer
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Kite, a Gilead company; Pfizer; Regeneron; Roche/Genentech; Stemline Therapeutics; Takeda
 
Jing Ye
Honoraria - Bristol-Myers Squibb; Janssen Biologics BV
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen
Research Funding - Celgene; Genmab; GlaxoSmithKline; MingSight; Novartis; Pfizer; Regeneron
 
Chalmer Tomlinson
Employment - Johnson & Johnson
 
Deeksha Vishwamitra
Employment - Johnson & Johnson
 
Indrajeet Singh
Employment - Johnson & Johnson
 
Xiang Qin
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Michela Campagna
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Tara Masterson
Employment - Johnson & Johnson
 
Veronique Vreys
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Bonnie Lau
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Jaszianne Tolbert
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Thomas Renaud
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Christoph Heuck
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Ajai Chari
Consulting or Advisory Role - Abbvie; Antengene; Bristol-Myers Squibb/Celgene; Genentech; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Takeda
Research Funding - Janssen
Travel, Accommodations, Expenses - Abbvie; Antengene; Bristol-Myers Squibb/Celgen; Genentech; Genzyme; Glaxo Smith Klinee; Janssen